{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:58:36Z","timestamp":1771037916904,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Alkermes Biopharmaceuticals"},{"name":"Aurobindo Pharma"},{"name":"Auromedics Pharma LLC"},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Otsuka Pharmaceuticals"},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sage Therapeutics, Inc."},{"DOI":"10.13039\/100009655","name":"Sunovion Pharmaceuticals, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009655","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015235","name":"Supernus Pharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015235","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00737-021-01162-z","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T03:30:57Z","timestamp":1627443057000},"page":"511-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical Antipsychotics"],"prefix":"10.1007","volume":"25","author":[{"given":"Adele C.","family":"Viguera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Vanderkruik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Gaccione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoebe S.","family":"Caplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren A.","family":"Kobylski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"issue":"10","key":"1162_CR1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1176\/ps.2008.59.10.1175","volume":"59","author":"RJ Baldessarini","year":"2008","unstructured":"Baldessarini RJ, Henk H, Sklar A, Chang J (2008) Leahy LPsychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv 59(10):1175\u20131183","journal-title":"Psychiatr Serv"},{"key":"1162_CR2","doi-asserted-by":"publisher","first-page":"986","DOI":"10.4088\/JCP.14br09418","volume":"76","author":"LS Cohen","year":"2015","unstructured":"Cohen LS, Viguera AC, McInerney KA et al (2015) Establishment of the National Pregnancy Registry for Atypical Antipsychotics. J Clin Psychiatry 76:986\u2013989","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"1162_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1176\/appi.ajp.2015.15040506","volume":"173","author":"LS Cohen","year":"2016","unstructured":"Cohen LS, Viguera AC, McInerney KA et al (2016) Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry 173(3):263\u2013270","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1162_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/0890334417695202","volume":"33","author":"ML Henninger","year":"2017","unstructured":"Henninger ML, Irving SA, Kauffman TL, Kurosky SK, Rompala K, Thompson MG, Sokolow LZ, Ammon Avalos L, Ball SW, Shifflett P, Naleway AL, Predictors of breastfeeding initiation and maintenance in an integrated healthcare setting (2017) Predictors of breastfeeding initiation and maintenance in an integrated healthcare setting. J Hum Lact. 33(2):256\u2013266","journal-title":"J Hum Lact."},{"issue":"12","key":"1162_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/bdr2.1077","volume":"109","author":"N Kronenfeld","year":"2017","unstructured":"Kronenfeld N, Berlin M, Shaniv D, Berkovitch M (2017) Use of psychotropic medications in breastfeeding women. Birth Defects Res 109(12):957-997.13","journal-title":"Birth Defects Res"},{"issue":"2","key":"1162_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/archgenpsychiatry.2008.528","volume":"66","author":"T Munk-Olsen","year":"2009","unstructured":"Munk-Olsen T, Laursen TM, Mendelson T, Pedersen CB, Mors O, Mortensen PB (2009) Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry 66(2):189\u2013195","journal-title":"Arch Gen Psychiatry"},{"key":"1162_CR7","doi-asserted-by":"crossref","unstructured":"Niforatos J, Swetlik C, Viguera A (2019) Antipsychotics and Lactation. In: Uguz F, Orsolini L (eds) Perinatal Psychopharmacology. Springer, Cham","DOI":"10.1007\/978-3-319-92919-4_8"},{"issue":"10","key":"1162_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.euroneuro.2016.08.008","volume":"26","author":"I Pacchiarotti","year":"2016","unstructured":"Pacchiarotti I, Le\u00f3n-Caballero J, Murru A, Verdolini N et al (2016) Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder. Eur Neuropsychopharmacol 26(10):1562\u20131578","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"1162_CR9","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1542\/peds.2011-3552","volume":"129","author":"Section on breastfeeding","year":"2012","unstructured":"Section on breastfeeding (2012) breastfeeding and the use of human milk. Pediatrics 129(3):e827\u2013e841. https:\/\/doi.org\/10.1542\/peds.2011-3552","journal-title":"Pediatrics"},{"issue":"2","key":"1162_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1176\/appi.ajp.157.2.179","volume":"157","author":"AC Viguera","year":"2000","unstructured":"Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 157(2):179\u2013184","journal-title":"Am J Psychiatry"},{"issue":"12","key":"1162_CR11","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1176\/appi.ajp.159.12.2102","volume":"159","author":"AC Viguera","year":"2002","unstructured":"Viguera AC, Cohen LS, Bouffard S, Whitfield TH, Baldessarini RJ (2002) Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry 159(12):2102","journal-title":"Am J Psychiatry"},{"key":"1162_CR12","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","volume":"164","author":"AC Viguera","year":"2007","unstructured":"Viguera AC, Whitfield T, Baldessarini RJ et al (2007a) Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 164:1817\u20132182","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1162_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1176\/ajp.2007.164.2.342","volume":"164","author":"AC Viguera","year":"2007","unstructured":"Viguera AC, Newport DJ, Ritchie J, Stowe Z, Whitfield T, Mogielnicki J, Baldessarini RJ, Zurick A, Cohen LS (2007b) Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 164(2):342\u20135","journal-title":"Am J Psychiatry."},{"issue":"2","key":"1162_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00737-009-0130-1","volume":"13","author":"AC Viguera","year":"2010","unstructured":"Viguera AC, Cohen LS, Whitfield T, Reminick AM, Bromfield E, Baldessarini RJ (2010) Perinatal use of anticonvulsants: differences in attitudes and recommendations among neurologists and psychiatrists. Arch Womens Ment Health 13(2):175\u2013178","journal-title":"Arch Womens Ment Health"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-021-01162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-021-01162-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-021-01162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T08:16:37Z","timestamp":1647245797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-021-01162-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1007\/s00737-021-01162-z","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"25 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the institutional review board of Massachusetts General Brigham (IRB reference # 2008P001861). For all participants, informed consent was obtained prior to data collection. Consent was obtained using Massachusetts Brigham IRB approved materials.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish the manuscript in the Archives of Women\u2019s Mental Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ACV: Research Support: National Pregnancy Registry for Atypical Antipsychotics: Alkermes Biopharmaceuticals; Aurobindo Pharma; Janssen\u00a0Pharmaceutica; Otsuka Pharmaceuticals; Sunovion Pharmaceuticals, Inc.; Teva Pharmaceuticals; Sage Therapeutics, Inc AuroMedics Pharma LLC,\u00a0Supernus Pharmaceuticals. Other Research Support: none. Advisory\/Consulting: Up-to-Date. Speaking\/Honoraria: none. Royalty\/patent, other income:\u00a0none.MPF: Research Support: National Pregnancy Registry for Atypical Antipsychotics: Alkermes Biopharmaceuticals; Aurobindo Pharma; Janssen\u00a0Pharmaceuticals; Otsuka Pharmaceuticals; Sunovion Pharmaceuticals Inc.; Teva Pharmaceuticals; Sage Therapeutics, Inc.; AuroMedics Pharma LLC;\u00a0Supernus Pharmaceuticals. Other Research Support: SAGE Therapeutics; as an employee of MGH, Dr. Freeman works with the MGH CTNI, which has\u00a0had research funding from multiple pharmaceutical companies and NIMH. Advisory\/consulting: Advisory Boards: Eliem, Sage; Independent Data\u00a0Safety and Monitoring Committee: Janssen (Johnson& Johnson), Novartis; Steering Committee for Educational Activities: Medscape; educational\u00a0activities: WebMD. Speaking\/Honoraria: none. Royalty\/patent, other income: none.LSC: Research Support: National Pregnancy Registry for Atypical Antipsychotics: Alkermes Biopharmaceuticals; Aurobindo Pharma; Janssen\u00a0Pharmaceutica; Otsuka Pharmaceuticals; Sunovion Pharmaceuticals, Inc.; Teva Pharmaceuticals; Sage Therapeutics, Inc, AuroMedics Pharma LLC,\u00a0Supernus Pharmaceuticals. Other research support: Brain & Behavior Research Foundation; National Institute on Aging; National Institutes of Health;\u00a0SAGE Therapeutics. Advisory\/consulting: JDS Therapeutics LLC; as an employee of MGH, Dr. Cohen works with the MGH CTNI, which has had research\u00a0funding from multiple pharmaceutical companies, including Alkermes Biopharmaceuticals and Praxis Precision Medicines, Inc., and the NIMH.\u00a0Speaking\/Honoraria: none. Royalty\/patent, other income: none.RV, PSC, LAK: Nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}